Development of a Procedure for Identification of Biperiden Hydrochloride with Specificity for Triperiden Hydrochloride

N. E. Kuz’mina; S. V. Moiseev; V. I. Krylov; A. A. Kutin; V. A. Yashkir; V. A. Merkulov

doi:10.1007/s11094-018-1749-x

Development of a Procedure for Identification of Biperiden Hydrochloride with Specificity for Triperiden Hydrochloride

Авторы: Kuz’mina N.E.¹, Moiseev S.V.¹, Krylov V.I.¹, Kutin A.A.¹, Yashkir V.A.¹, Merkulov V.A.¹
Учреждения:
1. Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
Выпуск: Том 51, № 12 (2018)
Страницы: 1106-1110
Раздел: Article
URL: https://journals.rcsi.science/0091-150X/article/view/244931
DOI: https://doi.org/10.1007/s11094-018-1749-x
ID: 244931

Цитировать

Полный текст

Открытый доступ
Доступ закрыт

Доступ предоставлен
Доступ закрыт

Только для подписчиков

Аннотация
Об авторах
Список литературы
Дополнительные файлы
Статистика

Аннотация

Biperiden hydrochloride, (1RS)-1-[(1RS, 2SR, 4RS)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)prop an-1-ol hydrochloride, is one of the most efficacious cholinolytics. It is used to treat Parkinson’s disease and various types of muscular spasms and to ameliorate uncoordinated muscular movements that can accompany the use of several tranquilizers [1, 2]. Biperiden appears in the vital and essential drug list that was approved by an order of the RF Government [3].